ArticleScientific reports2026
Isomeric diversity of GlcNAc(Man
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
N-linked glycosylation represents a critical post-translational modification that influences protein structure and function. Traditional model of N-glycan biosynthesis in multicellular eukaryotes propose that these glycans are assembled within the endoplasmic reticulum and Golgi apparatus via highly conserved pathways. According to this model, biosynthesis yields a single structural variant of GlcNAc(Man₃GlcNAc₂) and two variants of GlcNAc₂(Man₃GlcNAc₂), which then serve as the foundational precursors for all more complex N-glycan forms. In the present work, we employed mass spectrometry and enzymatic digestion to elucidate the structures of GlcNAc(Man₃GlcNAc₂) and GlcNAc₂(Man₃GlcNAc₂) isolated from a range of animal species and cell types. Structural assignments were independently validated through enzymatic synthesis approaches. Our analyses uncovered numerous glycan isomers that are not accounted for by the conventional biosynthetic model of mammalian cells, with several of these unexpected structures appearing as the predominant forms in multiple samples, indicating unusual enzymatic activities occur in some organisms and cell types, which are not universal but specialized. Examination of complex N-glycans obtained from fused lobes as well as MGAT-II, MGAT-IVa, and MGAT-IVb knockout strains of Drosophila melanogaster agrees to the two additional biosynthetic routes suggested in previous study. Collectively, these findings highlight the need for caution when assigning structures to GlcNAc(Man₃GlcNAc₂) and GlcNAc₂(Man₃GlcNAc₂) glycans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.